In the present study, despite the limited patient sample, TNBC was found at a significantly higher frequency among patients who succumbed to metastatic disease, compared to patients with ER+, PR+ and HER2−, confirming recent studies (8,14). Here, PGR is linked to metastatic neoplasm.